Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Other Operating Expenses of $3.1 million for Q1 2026, down 89.92% YoY from $31.2 million in Q1 2025, and up 105.01% sequentially from -$62.8 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Other Operating Expenses across 5 years of filings, most recently posting $3.1 million for Q1 2026.

  • In Q1 2026, Other Operating Expenses fell 89.92% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at -$46.0 million (down 326.74% YoY), while the FY2024 annual figure was $12.6 million, down 2.75% from the prior year.
  • Other Operating Expenses improved to $3.1 million in Q1 2026, from -$62.8 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for AMRN reached as high as $31.2 million in Q1 2025 and fell as low as -$74.2 million in Q4 2024.
  • The 5-year median for Other Operating Expenses is $7.9 million (2022), against an average of -$3.1 million.
  • Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 673.4% — and 2025, when it soared 336.73%.
  • A 5-year view of Other Operating Expenses shows it stood at $12.6 million in 2022, then grew by 2.4% to $12.9 million in 2023, then plunged by 673.4% to -$74.2 million in 2024, then climbed by 15.47% to -$62.8 million in 2025, then surged by 105.01% to $3.1 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $3.1 million, -$62.8 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.14 Mn
Dec 31, 2025 -62.76 Mn
Sep 30, 2025 13.60 Mn
Mar 31, 2025 31.20 Mn
Dec 31, 2024 -74.25 Mn
Sep 30, 2024 3.12 Mn
Jun 30, 2024 29.16 Mn
Dec 31, 2023 12.95 Mn
Dec 31, 2022 12.65 Mn
Jun 30, 2022 13,000.00